You're subscribed!

We're genuinely thrilled to have you onboard. By joining our community, you've gained access to the very latest in medcomms, expert insights, and invaluable discussions tailored for professionals like you. Stay tuned for a wealth of content designed for the fast-evolving world of pharmaceuticals and biotech.

Here are a couple of our favorite articles in the meantime:

6 Questions to Ask Before You Draft an Abstract

Early warning signs of publication rework — and how structured ownership, alignment and sequencing prevent costly revisions in medical communications.

How to Spot a Publication That Will Need Reworking (Before it Does)

Early warning signs of publication rework — and how structured ownership, alignment and sequencing prevent costly revisions in medical communications.

Three Conversations to Have With Your Publication Partner in January

Three strategic conversations to align expectations, anticipate pressure points, and set publication programmes up for a calm, well-run year.

Active Surveillance: Doing Nothing Is Sometimes Doing the Most

Active surveillance offers a science-led, patient-centred approach to low-risk prostate cancer—prioritising careful monitoring, clear communication and quality of life.